A detailed history of Bdf Gestion transactions in Moderna, Inc. stock. As of the latest transaction made, Bdf Gestion holds 19,323 shares of MRNA stock, worth $478,437. This represents 0.07% of its overall portfolio holdings.

Number of Shares
19,323
Previous 20,611 6.25%
Holding current value
$478,437
Previous $532 Million 7.03%
% of portfolio
0.07%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 09, 2026

SELL
$23.56 - $28.49 $30,345 - $36,695
-1,288 Reduced 6.25%
19,323 $570 Million
Q3 2025

Oct 09, 2025

SELL
$23.51 - $34.67 $100,763 - $148,595
-4,286 Reduced 17.21%
20,611 $532 Million
Q2 2025

Jul 11, 2025

SELL
$23.65 - $28.54 $64,186 - $77,457
-2,714 Reduced 9.83%
24,897 $687 Million
Q1 2025

Apr 17, 2025

BUY
$28.35 - $47.53 $782,771 - $1.31 Million
27,611 New
27,611 $783 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $9.69B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Bdf Gestion Portfolio

Follow Bdf Gestion and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bdf Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Bdf Gestion with notifications on news.